Information  X 
Enter a valid email address

Ixico PLC ORD 1P (IXI)

Date Time Source Announcement
11 Jun 2021 11:35 am
RNS
Holding(s) in Company
25 May 2021 7:00 am
RNS
Half yearly report to 31 March 2021
20 May 2021 7:00 am
RNS
Phase II Alzheimer's disease contract award
19 May 2021 7:00 am
RNS
Contract win for new neuroinflammatory disorder
11 May 2021 7:00 am
RNS
Notice of results
28 Apr 2021 7:00 am
RNS
Contract win for new stroke study
26 Apr 2021 7:00 am
RNS
Trading update
19 Apr 2021 8:21 am
RNS
Holding(s) in Company
12 Apr 2021 4:00 pm
RNS
Holding(s) in Company
  7:00 am
RNS
Investment in Ixico plc
01 Apr 2021 7:00 am
RNS
Holding(s) in Company
25 Mar 2021 9:14 am
RNS
PDMR Transaction
24 Mar 2021 9:05 am
RNS
Second Price Monitoring Extn
  9:00 am
RNS
Price Monitoring Extension
23 Mar 2021 4:40 pm
RNS
Second Price Monitoring Extn
  4:35 pm
RNS
Price Monitoring Extension
  3:05 pm
RNS
Huntington's disease Phase III contract updates
15 Mar 2021 4:41 pm
RNS
Second Price Monitoring Extn
  4:35 pm
RNS
Price Monitoring Extension
  2:06 pm
RNS
Second Price Monitoring Extn
  2:00 pm
RNS
Price Monitoring Extension
  11:06 am
RNS
Second Price Monitoring Extn
  11:01 am
RNS
Price Monitoring Extension
  7:00 am
RNS
Collaboration with Microsoft
10 Mar 2021 7:00 am
RNS
IXICO chosen for new Phase II AD study
02 Mar 2021 7:00 am
RNS
IXICO selected by Cyclerion for a new AD study
01 Mar 2021 5:25 pm
RNS
Exercise of Options; PDMR Dealing
  7:00 am
RNS
Conference attendance and presentations
29 Jan 2021 10:19 am
RNS
PDMR Dealing
21 Jan 2021 11:05 am
RNS
Result of AGM
07 Jan 2021 7:00 am
RNS
Issue of Equity
24 Dec 2020 7:00 am
RNS
IXICO secures new contract for �3.4 million
14 Dec 2020 11:54 am
RNS
Holding(s) in Company
08 Dec 2020 7:00 am
RNS
IXICO contract with new large global pharma
03 Dec 2020 2:06 pm
RNS
Second Price Monitoring Extn
  2:01 pm
RNS
Price Monitoring Extension
02 Dec 2020 7:00 am
RNS
Financial Results for the year ended 30 Sept 2020
27 Nov 2020 7:00 am
RNS
IXICO announces �1.9 million new study award
09 Nov 2020 7:00 am
RNS
Notice of Results
03 Nov 2020 7:00 am
RNS
Additional Alzheimer's disease contracts
22 Oct 2020 7:00 am
RNS
Further Huntington's disease contracts
19 Oct 2020 7:00 am
RNS
IXICO to Present at SCA & ARCA Global Conference
  7:00 am
RNS
Trading Update for year ended 30 September 2020
16 Oct 2020 7:00 am
RNS
IXICO and NYU Langone Health sign agreement
30 Sep 2020 2:05 pm
RNS
Second Price Monitoring Extn
  2:00 pm
RNS
Price Monitoring Extension
29 Sep 2020 7:00 am
RNS
>�2m contract extension win - Huntington's disease
24 Sep 2020 7:00 am
RNS
Collaboration with TRACK-FA NeuroimagingConsortium
21 Sep 2020 7:00 am
RNS
IXICO selected to support Alzheimer's trial
11 Sep 2020 10:36 am
RNS
Holding(s) in Company
26 Aug 2020 11:55 am
RNS
Investor presentation
24 Aug 2020 9:05 am
RNS
Second Price Monitoring Extn
  9:00 am
RNS
Price Monitoring Extension
  7:00 am
RNS
Trading Update
13 Aug 2020 7:00 am
RNS
Investor Presentation
08 Jul 2020 7:00 am
RNS
Conference attendance - On Helix Digital
06 Jul 2020 7:00 am
RNS
Grant of share options
24 Jun 2020 7:00 am
RNS
Trading Update
 
Headlines
Top categories
Company finder
Forthcoming announcements

a d v e r t i s e m e n t